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Background: Patient-rated outcome measures (PROMs) are an important part of clinical decision-making in rehabilitation
of patients with shoulder pain. The Disabilities of Arm, Shoulder and Hand (DASH) questionnaire was designed to
measure physical disability and symptoms in patients with musculoskeletal disorders of the upper extremity and
is one the most commonly used outcome measures for patients with shoulder pain. The purpose of this study
was to investigate the reliability and validity of the Norwegian version of the DASH in patients with shoulder impingement
syndrome.
Methods: Sixty-three patients diagnosed with shoulder impingement syndrome at an orthopaedic outpatient clinic were
included in the study. Internal consistency of the DASH was evaluated by the Cronbach’s alpha and item-to-total
correlations. Test-retest reliability was analyzed by the intraclass correlation coefficient (ICC) and limits of agreement
(LoA) according to the Bland Altman method. Standard error of measurement (SEM) and minimally detectable change
(MDC) were calculated for the total DASH score. Construct validity was evaluated by testing six a priori hypotheses for
the Pearson’s correlation coefficient between the DASH and the Shoulder Pain and Disability Index (SPADI), the 36-item
Short Form Health Survey (SF-36) and a Numeric Pain Rating Scale (NPRS).
Results: Reliability: Cronbach’s alpha of the DASH was 0.93 and item-to-total correlations ranged from 0.36 to 0.81. ICC
was 0.89. The 95 percent LoA was calculated to be between −11.9 and 14.1. SEM was 4.7 and MDC 13.1. Construct
validity: Eighty-three percent of the a priori hypotheses of correlation were confirmed. The DASH showed a high
positive correlation of 0.75 with the SPADI, a negative moderate correlation of −0.48 to −0.62 with physical functioning,
bodily pain and physical component summary of the SF-36 and a moderate positive correlation of 0.58 with the NPRS.
DASH correlated higher with the physical component summary than with the mental component summary of the SF-36.
Conclusions: The Norwegian version of the DASH is a reliable and valid outcome measure for patients with shoulder
impingement syndrome.
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Patient-rated outcome measures (PROMs) are an import-
ant part of clinical decision making in rehabilitation of pa-
tients with shoulder pain. A number of PROMs are
available [1,2], of which the Disabilities of the Arm, Shoul-
der and Hand (DASH) outcome measure is one of the
most commonly used. The DASH is a condition-specific
PROM developed to assess physical disability and symp-
toms in people with musculoskeletal disorders of the
upper extremity [3-5]. The original English version of the
DASH has been translated and adapted into many lan-
guages [5,6]. It has shown to be reliable, valid and respon-
sive in patients with shoulder pathologies [1,4,7].
Shoulder impingement syndrome is the most common
clinical diagnosis for patients with shoulder pain [8,9]
and can be defined as a symptomatic compression of the
subacromial structures during elevation of the arm
[10,11]. The main symptom is anterior-lateral shoulder
pain when lifting the arm above shoulder level and dur-
ing overhead activities. Contributing factors to the devel-
opment of shoulder impingement syndrome include
inflammation of the tendons and bursa, degeneration of
the tendons, postural dysfunctions and weak or dysfunc-
tional rotator cuff and scapular musculature [10,11].
Various terms are used for the same condition such as
rotator cuff disease/tendinopathy, subacromial impinge-
ment syndrome and painful arc syndrome.
Measurement properties of an outcome measure are re-
lated to the population and context in which it is used. Be-
fore a translated outcome measure can be used with
confidence in clinical or research settings, the measure-
ment properties of the translated version need to be deter-
mined [12]. The measurement properties of the Norwegian
language version of the DASH have not previously been in-
vestigated in non-rheumatic patients with shoulder pain.
The objective of this study was to examine the reliability
and construct validity of the DASH in patients with shoul-
der impingement syndrome.
Methods
Patients
The patients were recruited from an outpatient clinic from
December 2007 to October 2010. We included adult pa-
tients with the primary diagnosis of shoulder impinge-
ment syndrome (M75.4 in the ICD-10). The patients were
diagnosed by an orthopaedic surgeon and screened for in-
clusion in the study by a physiotherapist. The impinge-
ment diagnosis was based on reported symptoms and
clinical findings such as anterior-lateral shoulder pain
worsening during elevation of the arm and overhead activ-
ities, normal or close to normal passive range of motion of
the shoulder and positive impingement sign [13].
Patients were excluded from the study if they had gen-
eralized pain, symptoms of cervical spine disease, hadundergone surgery in the affected shoulder within the
last six months or were unable to understand written
and spoken Norwegian. In addition, patients were ex-
cluded if they had been diagnosed with any rheumato-
logic illness, chronic systemic disease or cardiac disease.
Measures
The Disabilities of the Arm, Shoulder and Hand
questionnaire (DASH)
The DASH was developed by the Institute for Work and
Health and the American Academy of Orthopaedic Sur-
geons (AAOS) [3-5]. It was designed to be a discrimina-
tive and evaluative measure of physical disability and
symptoms in patients with musculoskeletal disorders of
the upper extremity, assessing the condition of the pa-
tient during the past week. It measures whether the re-
spondent has the capacity to do an activity, regardless of
how it is performed. The main part of the questionnaire,
the DASH disability/symptoms score, contains 30 items:
21 items about the ability to perform certain physical ac-
tivities, 5 items about the severity of pain, activity-
related pain, tingling, weakness and stiffness and 4 items
concerning the effect of the upper extremity problem on
social activities, work, sleep and self-image. Each item is
scored on a five-point ordinal scale. To calculate the
DASH score all completed responses are summed and
averaged. This value is subtracted by one and multiplied
by 25, giving a total score ranging from best to worst on
a 0–100 scale. At least 27 of the 30 items must be com-
pleted to calculate a score. The translation and adapta-
tion process of the Norwegian language version of the
DASH is described by Finsen (in Norwegian) [14].
The Shoulder Pain and Disability Index (SPADI)
The SPADI was designed to measure pain and disability
in patients with shoulder disorders [15]. A Norwegian
version is available [16]. It is a 13-item PROM divided
into two subscales: the five-item pain subscale and the
eight-item disability subscale. Each item in the original
version is scored on a visual analogue scale from from 0
(no pain/no difficulty) to 11 (worst pain imaginable/ so
difficult required help). The pain and disability scores
are equally weighted and added for the total SPADI
score, ranging from best to worst on a 0–100 scale. The
Norwegian version of the SPADI has shown to have ac-
ceptable reliability and validity in patients with rotator
cuff disease [17].
The Short Form 36 Health Survey (SF-36)
The 36 item Short Form Health Survey is a generic
PROM developed to assess eight health domains [18]:
physical functioning (PF), role-physical (RP), bodily pain
(BP), general health (GH), vitality (VT), social function-
ing (SF), role-emotional (RE) and mental health (MH).
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0–100 scale. Two summary scores representing physical
(Physical component summary; PCS) and mental health
(Mental component summary; MCS) can be calculated.
We used the Norwegian version 1.2 [19]. The measure-
ment properties of the SF-36 have been tested exten-
sively [18].
Numeric Pain Rating Scale (NPRS)
The patients were asked to rate their pain on average
over the last week prior to assessment using an 11-point
Numeric Pain Rating Scale from 0 (no pain) - 10 (worst
possible pain) [20]. The NPRS is a commonly used out-
come measure for patients with shoulder pain and has
shown to be reliable and valid [21].
Procedures
Each patient was scheduled for two visits approximately
one week apart. At the first visit the patients filled out
the DASH, SPADI, SF-36 and Numeric Pain Rating
Scale. Descriptive data such as age, sex, symptom dur-
ation and employment status were also collected. At the
second visit the patients filled out the DASH and SPADI
and they were asked if the shoulder condition had chan-
ged since the first visit. The patients did not receive any
treatment between the first and the second visit. The
study protocol was approved by the Regional commit-
tees for medical and health research ethics (REC South
East), and was carried out in accordance with the
Helsinki Declaration. We obtained written informed
consent from all the participants at inclusion.
Statistical analysis
QualityMetric Health Outcomes Scoring Software 3.0
(QualityMetric Inc, Lincoln, Rhode Island, USA) was
used to manage missing SF-36 data and to calculate the
SF-36 scores. PAWS Statistics 18.0 for Windows (SPSS
Inc, Chicago, Illinois, USA) and the Stata/IC 11.2 for
Mac (StataCorp, College Station, Texas, USA) were used
for the other analysis. Floor and ceiling effects were evalu-
ated using histograms, and were considered to be present
if more than 15% of the respondents achieved the lowest
or highest possible score, respectively [22]. P-values less
than 0.05 were considered statistically significant.
Reliability
Internal consistency was assessed using Cronbach’s alpha
and item-to-total correlation coefficient. A Cronbach’s
alpha between 0.70 and 0.95 was considered to indicate
a good internal consistency [22]. Item-to-total correla-
tions above 0.3 were considered good [23]. Test-retest
reliability was calculated with the use of intraclass cor-
relation coefficient (ICC); 2.1-two-way random effect
model single measures. The ICC classifications of Fleisswere used to interpret the ICC values [24]: ICCs above
0.75 may indicate excellent reliability, values between
0.40 and 0.75 fair to good reliability and values below
0.40 poor reliability. All patients who reported their
shoulder pain as unchanged between the first and the
second visit were included in the test-retest reliability
analysis. Measurement error was assessed by estimating
the standard error of measurement (SEM), minimally
detectable change (MDC) and limits of agreement (LoA).
SEM was calculated as the square root of the within-
subject total variance of an ANOVA analysis [25]. The
MDC was calculated as
ffiffiffi
2
p  SEM [26]. The 95 percent
confidence interval for the SEM (SEM95) and MDC
(MDC95) was calculated by multiplying by the z-score of
1.96. LoA was calculated according to the Bland-Altman
method [27] and a LoA plot was made for visual judge-
ment. A paired t-test was performed to determine the sys-
tematic difference between the DASH scores at test and
retest.Construct validity
Construct validity was evaluated by testing six a priori
hypotheses for the Pearson’s correlation coefficient be-
tween the DASH and the SPADI, SF-36 and the NPRS.
A priori hypotheses were made based on the conceptual
model of the measures and results of previous studies.
As suggested by Rowntree [28] correlation coefficients
below 0.2 were considered as very weak or negligible,
between 0.2 and 0.4 as weak or low, between 0.4 and 0.7
as moderate, between 0.7 and 0.9 as strong, high or
marked, and above 0.9 as very strong or very high. We
hypothesized a high and positive correlation (0.7 to 0.9)
between the DASH total score and the SPADI total
score. We expected a negative, moderate correlation
(−0.4 to −0.7) with the PF, BP, and PCS score of the SF-
36. Furthermore, we hypothesized a negative, moderate
correlation with the SF of the SF-36. The DASH score
was expected to correlate higher with the PCS of the SF-
36 than with the MCS.Results
Ninety-four patients met the inclusion criteria, of whom
29 were unwilling or unable to participate in the study
and two were excluded because of generalized pain. Sixty-
three patients (30 women, 33 men), with a mean age of 53
(Standard deviation [SD] 12.9) years, were included in the
study. The mean duration of symptoms was 46.6 (SD
72.3) months, ranging from 2 to 420 months. Descriptive
characteristics of the patients are shown in Table 1. Mean
interval between the first and the second visit was 7.5 (SD
2.1) days, ranging from 7 to 21 days. Four missing values
were found in both the DASH and SPADI at retest (com-
pletion rate, 93.7%) and these subjects were excluded in
Table 1 Descriptive characteristics of the patients n = 63
Variable No. (%) or mean ± SD
Age, years 53.3 ± 12.9
Women 30 (48)
Men 33 (52)
Symptom duration, months 46.6 ± 72.3
Affected shoulder
Right 19 (48)
Left 30 (30)
Bilateral 14 (22)
Working/student full time 29 (46)
Sick listed 100% 8 (13)
Partial sick listed 9 (14)
Retired 14 (22)
Receiving disability benefit 2 (3)
Unemployed 1 (2)
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Figure 1 Limits of agreement plot n = 59. The difference in scores
between DASH test and retest DASH plotted against the average
scores of both test occasions. The middle dotted line represents
mean difference (1.1). The bottom and top dotted line represent the
95% limits of agreement (−11.9, 14.1). Four out of 59 (6.8%) were
outside the limits of agreement.
Table 3 Descriptive statistics of the DASH, SPADI, SF-36
and NPRS at test and Pearson’s correlation coefficients
for DASH n = 63
Correlations
Mean SD DASH p-value
The Disabilities of the Arm, Shoulder
and Hand questionnaire (DASH)
29.4 13.8 - -
The Shoulder Pain and Disability
Index (SPADI)
36.2 16.6 0.75 <0.001
Numeric Pain Rating Scale (NPRS) 4.1 2.0 0.58 <0.001
The Short Form 36 Health Survey
(SF-36)
Physical functioning 77.9 14.8 −0.48 <0.001
Role-physical 35.3 37.7 −0.49 <0.001
Bodily pain 44.3 15.3 −0.62 <0.001
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measurement error. Two missing values (RP and MH)
were found in the SF-36 (completion rate, 99.9%). The
SF-36 records were scored with the QualityMetric’s
missing data estimation (MDE). The DASH scores
were considered to be normally distributed. No floor
or ceiling effects were found. The scores ranged from
8.3 to 58.6 at the first visit and from 5.0 to 58.6 at the
second visit.
Reliability
Reliability data are presented in Table 2. The internal
consistency estimate (n = 63) of Cronbach’s alpha was
0.93. Item-to-total correlations ranged from 0.36 to 0.81.
The DASH mean score (n = 59) at the first visit was 29.5
(SD 14.0) and at the second visit 28.4 (SD 14.0), giving a
mean difference of 1.1 (SD 6.64) (95% confidence inter-
val [CI] -0.65 to 2.82). ICC (n = 59) was 0.89 (95% CI
0.82 to 0.93). The SEM was 4.7 and SEM95 was 8.3. The
MDC was 6.7 and MDC95 was 13.1. The 95% LoA was
calculated to be between −11.9 and 14.1, and 4 out of 59
(6.8%) were outside the LoA (Figure 1).
Construct validity
The statistical analysis of correlation coefficients between
DASH and the SPADI, SF-36 and NPRS are shown inTable 2 Cronbach’s alpha, item-to-total correlations,
intraclass correlation coefficient (ICC), standard error of
measurement (SEM) and minimally detectable change
(MDC95) of the Norwegian version of the DASH
Cronbach’s
alpha
Item-to-total
correlations
ICC (95% CI) SEM MDC95
0.93 0.36-0.81 0.89 (0.82-0.93) 4.7 13.1Table 3. We found a high positive correlation between the
DASH and SPADI (0.75). The DASH showed a moderate
negative correlation with the PF (−0.48), BP (−0.62), and
PCS (−0.59) of the SF-36, and a moderate positive correl-
ation with the NPRS (0.58). The DASH correlated higher
with the PCS (−0.59) than with the MCS (−0.17) score. It
had a low negative correlation to the SF (−0.35) of the
SF-36. All correlations were in line with a priori hy-
potheses except the low negative correlation to the SFGeneral health 73.3 20.2 −0.30 0.018
Vitality 54.1 21.5 −0.41 0.001
Social functioning 84.9 18.7 −0.35 0.005
Role-emotional 70.4 39.8 −0.25 0.051
Mental health 78.8 15.2 −0.28 0.029
Physical component summary 38.3 7.0 −0.59 <0.001
Mental component summary 50.9 10.1 −0.17 0.179
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the hypotheses of correlation were confirmed.
Discussion
Our results provide evidence for good reliability and val-
idity of the Norwegian language version of the DASH in
patients with shoulder impingement syndrome. The re-
sults are comparable to those reported for the original
English version and other language versions.
Reliability
The Cronbach’s alpha coefficient of 0.93 indicated a
good internal consistency and is similar to previous re-
ported values. In the original version [5] and other lan-
guages versions [29-31] the reported Cronbach’s alpha
was 0.96. A value of 0.93 was also reported for the Nor-
wegian language version in patients with rheumatic dis-
eases [32]. A Cronbach’s alpha between 0.70 and 0.95
have been proposed as a measure of good internal
consistency [22].
Internal consistency assessed by item-to-total correla-
tions ranged from 0.36 to 0.81.The item-to-total correla-
tions were above the threshold value of 0.3, suggesting
that the correlation between each item and the total
score of the questionnaire were acceptable. Item-to-total
correlations reported for the original English version of
the DASH ranged from 0.49 to 0.87 [33]. Values re-
ported for other language versions of the DASH ranged
from 0.27-0.88 [30,34,35].
The test-retest reliability of the DASH was calculated
to 0.89, which is considered to be excellent [24]. Studies
for other languages versions have also shown high test-
retest reliability with ICC values varying from 0.82 to
0.96, [30,36-42]. We retested the patients after approxi-
mately one week, which is within the recommended
time frame ranging from two days to two weeks [43].
Due to this short time interval, most of the patients re-
ported their shoulder pain as unchanged at the second
visit.
In order to detect any systematic changes, the mean
difference between the DASH test and retest was visual-
ized in a limits of agreement plot. The limits of agree-
ment plot may reveal systematic changes between the
difference and the average of the DASH or outlying ob-
servations. Four out of 59 (6.8%) observations exceeded
the limits of agreement. The mean difference between
DASH test and retest was 1.1 (95% CI −0.65 to 2.82)
and showed no systematic change. There was no appar-
ent tendency for the mean difference to vary systematic-
ally with the average score.
The SEM was 4.7 points, SEM95 was 8.3 and the
MDC95 was 13.1. These results correspond well with the
measurement error values reported for the original Eng-
lish version with a SEM of 4.6 points and a MDC95 of12.8 points [40]. The interpretation of SEM95 is that if a
patient has a measured DASH score of for example 50
points at an initial test, the clinician can be 95 percent
confident that the patient’s true score lies somewhere
between 42 and 58 DASH points. The MDC95 of 13.1
indicates that the clinician can be 95 percent confident
that a change has occured if the measured DASH score
at retest has changed more than 13.1 points.
A distinction between MDC and minimally important
change (MIC) is useful when interpreting change scores
in PROMs [26]. The MDC is a measure of the statisti-
cally important change. The MIC can be defined as the
smallest change in score which is perceived as important
by patients, clinicians, or relevant others [26,44]. Differ-
ent methods may be used to estimate this threshold
value which indicates if a patient is better or worse [45].
A change above 15 points is found to be above most es-
timates of MIC for the DASH, and is considered to be
the most accurate change score for discriminating be-
tween improved and unimproved patients [5].
Construct validity
Our results of construct validity agree with previous
studies [5]. The expected high positive correlation be-
tween DASH and SPADI was confirmed with a correl-
ation coefficient of 0.75. Both the DASH and SPADI
intend to measure activity limitations and pain (symp-
toms). However, there are differences in the content of
these questionnaires. The DASH is found to be more
wide-ranging than the SPADI and can be linked to 23
categories of the International Classification of Function-
ing, Disability and Health model (ICF), whereas SPADI
is linked to six categories [46].
We had hypothesized a moderate and negative correl-
ation with the Social Functioning domain of the SF-36,
because the DASH is also meant to measure compo-
nents of the social dimension: family care, occupational
and socializing with friends and relatives. A moderate
correlation with the Social Functioning of SF-36 has
been reported in several other languages versions with
correlation coefficients ranging from −0.53 to −0.64
[31,36,47-49]. The expected moderate negative correl-
ation with the SF subscale of SF-36 was not confirmed.
The low negative correlation to the SF (−0.35) may in-
dicate that the Norwegian language version of DASH
to a limited degree identifies the social dimension of
functional status in this population, as measured by
the SF-36.
DASH scores
The DASH questionnaire measures whether the re-
spondent has the capacity to do an activity, regardless of
how it is performed. It is scored from 0 (best) to 100
(worst). A mean DASH score of 10 have been reported
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mean score of 13 have been reported for both the gen-
eral population in Norway [50] and a working popula-
tion in Germany [51]. A Norwegian study of physical
function in adult acquired major upper-limb amputees
reported a mean DASH score of 22.7 [52]. The mean
score of 29.4 (SD ± 13.8) in our study population indi-
cated a more severe level of disability compared with
these populations. The level of disability in our study
population is comparable to other studies of patients
with shoulder impingement syndrome [53,54].
Study limitations
The DASH was designed to measure physical function
and symptoms in patients with musculoskeletal disor-
ders of the upper extremity. The results in this study are
limited to patients with the primary diagnosis of shoul-
der impingement syndrome and can not be generalized
to other disorders of the upper extremity. Another limi-
tation of this study is that we did not evaluate respon-
siveness, which has been defined as the ability of a
questionnaire to detect change over time in the con-
struct to be measured [55]. Responsiveness is considered
as an important measurement property of a PROM used
for treatment evaluation and needs to be evaluated for
the Norwegian version in future research.
Conclusions
This study demonstrated excellent test-retest reliability,
good internal consistency and established error values for
the Norwegian language version of the DASH. Further-
more, this study provided evidence supporting the DASH
as a valid measure of physical disability and symptoms in
patients with shoulder impingement syndrome.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
IS and BH obtained funding for the study. All authors participated in
planning and design of the study. IS and BH collected and analyzed the
data. BH drafted the manuscript. All authors contributed to interpretation of
the study results and participated in revisions of the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We would like to thank all the patients who participated in the study and
Gerty Lund and Ingrid Walter who contributed to the data collection. The
study was funded by The Norwegian Fund for Post-graduate Training in
physiotherapy and Bergesens Almennyttige Stiftelse (Bergesen’s Foundation).
The Open Access article-processing charge for this article was funded by
Martina Hansens Hospital.
Author details
1Department of Physiotherapy, Martina Hansens Hospital, Pb 823, 1346
Sandvika, Bærum, Norway. 2Norwegian Research Center for Active
Rehabilitation (NAR), Department of Orthopaedics, Oslo University Hospital,
Oslo, Norway. 3Department of Physiotherapy, Faculty of Health Sciences, Oslo
and Akershus University College of Applied Sciences, Pb 4, St. Olavs plass,
0130 Oslo, Norway.Received: 27 September 2013 Accepted: 4 March 2014
Published: 12 March 2014References
1. Bot SDM, Terwee CB, van der Windt DAWN, Bouter LM, Dekker J, de Vet
HCW: Clinimetric evaluation of shoulder disability questionnaires: a
systematic review of the literature. Ann Rheum Dis 2004, 63:335–341.
2. Angst F, Schwyzer HK, Aeschlimann A, Simmen BR, Goldhahn J: Measures
of adult shoulder function: Disabilities of the Arm, Shoulder, and Hand
Questionnaire (DASH) and its short version (QuickDASH), Shoulder Pain
and Disability Index (SPADI), American Shoulder and Elbow Surgeons
(ASES) Society standardized shoulder assessment form, Constant
(Murley) Score (CS), Simple Shoulder Test (SST), Oxford Shoulder Score (OSS),
Shoulder Disability Questionnaire (SDQ), and Western Ontario Shoulder
Instability Index (WOSI). Arthritis Care Res 2011, 63(Suppl 11):S174–S188.
3. Hudak PL, Amadio PC, Bombardier C, Beaton D, Cole D, Davies A, Hawker G,
Katz JN, Makela M, Marx RG, Punnett L, Wright J: Development of an upper
extremity outcome measure: The DASH (disabilities of the arm, shoulder
and hand). Am J Ind Med 1996, 29:602–608.
4. Beaton DE, Davis AM, Hudak P, McConnell S: The DASH (Disabilities of the
Arm, Shoulder and Hand) Outcome Measure: What do we know about it
now? Br J Hand Ther 2001, 6:109–118.
5. Kennedy CA, Beaton DE, Solway S, McConnell S, Bombardier C: The DASH
and QuickDASH Outcome Measure User’s Manual. 3rd edition. Toronto,
Ontario: Institute for Work & Health; 2011.
6. The DASH outcome measure website. http://www.dash.iwh.on.ca/.
7. Roy JS, MacDermid JC, Woodhouse LJ: Measuring shoulder function: a
systematic review of four questionnaires. Arthritis Care Res 2009, 61:623–632.
8. Van der Windt DAWM, Koes BW, de Jong BA, Bouter LM: Shoulder
disorders in general practice: incidence, patient characteristics, and
management. Ann Rheum Dis 1995, 54:959–964.
9. Silva L, Andréu JL, Muñoz P, Pastrana M, Millán I, Sanz J, Barbadillo C,
Fernández-Castro M: Accuracy of physical examination in subacromial
impingement syndrome. Rheumatology (Oxford) 2008, 47:679–683.
10. Bigliani LU, Levine WN: Current concepts review. Subacromial
impingement syndrome. J Bone Joint Surg 1997, 79:1854–1868.
11. Michener LA, McClure PW, Karduna AR: Anatomical and biomechanical
mechanisms of subacromial impingement syndrome. Clin Biomech (Bristol,
Avon) 2003, 18:369–379.
12. McKenna SP, Doward LC: The translation and cultural adaptation of
patient-reported outcome measures. Value Health 2005, 8:89–91.
13. Hawkins RJ, Kennedy JC: Impingement syndrome in athletes. Am J Sports
Med 1980, 8:151–158.
14. Finsen V: Norwegian version of the DASH questionnaire for evaluation of
the arm, shoulder and hand. Tidsskr Nor Laegeforen 2008, 128:1070 (In
Norwegian).
15. Roach KE, Budiman-Mak E, Songsiridej N, Lertratanakul Y: Development of a
shoulder pain and disability index. Arthritis Care Res 1991, 4:143–149.
16. Tveitå EK, Ekeberg OM, Juel NG, Bautz-Holter E: Responsiveness of the
shoulder pain and disability index in patients with adhesive capsulitis.
BMC Musculoskelet Disord 2008, 9:161.
17. Ekeberg OM, Bautz-Holter E, Tveitå EK, Keller A, Juel NG, Brox JI: Agreement,
reliability and validity in 3 shoulder questionnaires in patients with rota-
tor cuff disease. BMC Musculoskelet Disord 2008, 9:68.
18. SF-36.org. http://www.sf-36.org/.
19. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK: Translation and performance of
the Norwegian SF-36 health survey in patients with rheumatoid arthritis.
I. data quality, scaling assumptions, reliability, and construct validity.
J Clin Epidemiol 1998, 51:1069–1076.
20. Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA:
Studies with pain rating scales. Ann Rheum Dis 1978, 37:378–381.
21. Mintken PE, Glynn P, Cleland JA: Psychometric properties of the
shortened disabilities of the Arm, Shoulder, and Hand Questionnaire
(QuickDASH) and Numeric Pain Rating Scale in patients with shoulder
pain. J Shoulder Elbow Surg 2009, 18:920–926.
22. Terwee CB, Bot SDM, de Boer MR, van der Windt DAWN, Knol DL, Dekker J,
Bouter LM, de Vet HCW: Quality criteria were proposed for measurement
properties of health status questionnaires. J Clin Epidemiol 2007, 60:34–42.
23. Field AP: Discovering statistics using SPSS. Los Angeles, [Calif.]; London: SAGE;
2009.
Haldorsen et al. BMC Musculoskeletal Disorders 2014, 15:78 Page 7 of 7
http://www.biomedcentral.com/1471-2474/15/7824. Fleiss JL: The Design and Analysis of Clinical Experiments. New York: Wiley;
1986.
25. Weir JP: Quantifying test-retest reliability using the intraclass correlation
coefficient and the SEM. J Strength Cond Res 2005, 19:231.
26. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM:
Minimal changes in health status questionnaires: distinction between
minimally detectable change and minimally important change. Health
Qual Life Outcomes 2006, 4:54.
27. Bland JM, Altman DG: Measuring agreement in method comparison
studies. Stat Meth Med Res 1999, 8:135–160.
28. Rowntree D: Statistics without tears: a primer for non-mathematicians.
Boston: Allyn and Bacon; 2004.
29. Offenbächer M, Ewert T, Sangha O, Stucki G: Validation of a German
version of the Disabilities of Arm, Shoulder and Hand questionnaire
(DASH-G). Z Rheumatol 2003, 62:168–177.
30. Atroshi I, Gummesson C, Andersson B, Dahlgren E, Johansson A: The
disabilities of the arm, shoulder and hand (DASH) outcome
questionnaire. Acta Orthop Scand 2000, 71:613–618.
31. Themistocleous GS, Goudelis G, Kyrou I, Chloros GD, Krokos A, Galanos A,
Gerostathopoulos NE, Soucacos PN: Translation into Greek, cross-cultural
adaptation and validation of the Disabilities of the Arm, Shoulder, and
Hand Questionnaire (DASH). J Hand Ther 2006, 19:350–357.
32. Christie A, Hagen KB, Mowinckel P, Dagfinrud H: Methodological properties
of six shoulder disability measures in patients with rheumatic diseases
referred for shoulder surgery. J Shoulder Elbow Surg 2009, 18:89–95.
33. Hunsaker FG, Cioffi DA, Amadio PC, Wright JG, Caughlin B: The American
Academy of Orthopaedic Surgeons outcomes instruments: normative
values from the general population. J Bone Joint Surg 2002, 84:208–215.
34. Durand MJ, Vachon B, Hong QN, Loisel P: The cross-cultural adaptation of
the DASH questionnaire in Canadian French. J Hand Ther 2005, 18:34–39.
35. Lee EWC, Lau JSY, Chung MMH, Li APS, Lo SK: Evaluation of the Chinese
version of the Disability of the Arm, Shoulder and Hand (DASH-HKPWH):
cross-cultural adaptation process, internal consistency and reliability
study. J Hand Ther 2004, 17:417–423.
36. Padua R, Padua L, Ceccarelli E, Romanini E, Zanoli G, Amadio PC, Campi A:
Italian version of the Disability of the Arm, Shoulder and Hand (DASH)
questionnaire. Cross-cultural adaptation and validation. J Hand Surg Br
2003, 28:179–186.
37. Imaeda T, Toh S, Nakao Y, Nishida J, Hirata H, Ijichi M, Kohri C, Nagano A:
Validation of the Japanese Society for Surgery of the Hand version of
the Disability of the Arm, Shoulder, and Hand questionnaire. J Orthop Sci
2005, 10:353–359.
38. Fayad F, Lefevre-Colau MM, Macé Y, Fermanian J, Mayoux-Benhamou A,
Roren A, Rannou F, Roby-Brami A, Gautheron V, Revel M, Poiraudeau S:
Validation of the French version of the Disability of the Arm, Shoulder
and Hand questionnaire (F-DASH). Joint Bone Spine 2008, 75:195–200.
39. Mousavi SJ, Parnianpour M, Abedi M, Askary-Ashtiani A, Karimi A, Khorsandi A,
Mehdian H: Cultural adaptation and validation of the Persian version of the
Disabilities of the Arm, Shoulder and Hand (DASH) outcome measure. Clin
Rehabil 2008, 22:749–757.
40. Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C:
Measuring the whole or the parts? Validity, reliability, and
responsiveness of the Disabilities of the Arm, Shoulder and Hand
outcome measure in different regions of the upper extremity. J Hand
Ther 2001, 14:128–142.
41. Orfale AG, Araújo PMP, Ferraz MB, Natour J: Translation into Brazilian
Portuguese, cultural adaptation and evaluation of the reliability of the
disabilities of the arm, shoulder and hand questionnaire. Braz J Med Biol
Res 2005, 38:293.
42. Slobogean GP, Noonan VK, O’Brien PJ: The reliability and validity of the
disabilities of arm, shoulder, and hand, EuroQol-5D, health utilities index,
and Short Form-6D outcome instruments in patients with proximal
humeral fractures. J Shoulder Elbow Surg 2010, 19:342–348.
43. Marx RG, Menezes A, Horovitz L, Jones EC, Warren RF: A comparison of two
time intervals for test-retest reliability of health status instruments. J Clin
Epidemiol 2003, 56:730–735.
44. de Vet HCW: The minimal detectable change should not replace the
minimal important difference. J Clin Epidemiol 2010, 63:804–805.
45. Beaton DE, van Eerd D, Smith P, van der Velde G, Cullen K, Kennedy CA,
Hogg-Johnson S: Minimal change is sensitive, less specific to recovery: adiagnostic testing approach to interpretability. J Clin Epidemiol 2011,
64:487–496.
46. Roe Y, Soberg HL, Bautz-Holter E, Ostensjo S: A systematic review of
measures of shoulder pain and functioning using the International
classification of functioning, disability and health (ICF). BMC Musculoskelet
Disord 2013, 14:73.
47. SooHoo NF, McDonald AP, Seiler JG, McGillivary GR: Evaluation of the
construct validity of the DASH questionnaire by correlation to the SF-36.
J Hand Surg Am 2002, 27:537–541.
48. Raven EEJ, Haverkamp D, Sierevelt IN, van Montfoort DO, Pöll RG,
Blankevoort L, Tak PP: Construct validity and reliability of the disability of
arm, shoulder and hand questionnaire for upper extremity complaints in
rheumatoid arthritis. J Rheumatol 2008, 35:2334–2338.
49. Lee EWC, Chung MMH, Li APS, Lo SK: Construct validity of the Chinese
version of the disabilities of the arm, shoulder and hand questionnaire
(DASH-HKPWH). J Hand Surg Br 2005, 30:29–34.
50. Aasheim T, Finsen V: The DASH and the QuickDASH instruments.
Normative values in the general population in Norway. J Hand Surg Eur
Vol 2014, 39:140–144.
51. Jester A, Harth A, Germann G: Measuring levels of upper-extremity
disability in employed adults using the DASH Questionnaire. J Hand Surg
Am 2005, 30:1074. e1-1074.e10.
52. Ostlie K, Franklin RJ, Skjeldal OH, Skrondal A, Magnus P: Assessing physical
function in adult acquired major upper-limb amputees by combining the
Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Questionnaire
and clinical examination. Arch Phys Med Rehabil 2011, 92:1636–1645.
53. de Witte PB, Henseler JF, Nagels J, Vliet Vlieland TP, Nelissen RG: The
Western Ontario rotator cuff index in rotator cuff disease patients: a
comprehensive reliability and responsiveness validation study. Am J
Sports Med 2012, 40:1611–1619.
54. Roy JS, Moffet H, McFadyen BJ: Upper limb motor strategies in persons
with and without shoulder impingement syndrome across different
speeds of movement. Clin Biomech (Bristol, Avon) 2008, 23:1227–1236.
55. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter
LM, de Vet HC: The COSMIN study reached international consensus on
taxonomy, terminology, and definitions of measurement properties for
health-related patient-reported outcomes. J Clin Epidemiol 2010, 63:737–745.
doi:10.1186/1471-2474-15-78
Cite this article as: Haldorsen et al.: Reliability and validity of the
Norwegian version of the Disabilities of the Arm, Shoulder and Hand
questionnaire in patients with shoulder impingement syndrome. BMC
Musculoskeletal Disorders 2014 15:78.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
